BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 885163)

  • 1. Influence of several anesthetic agents on the effect of delta9-tetrahydrocannabinol on the heart rate and blood pressure of the mongrel dog.
    Jandhyala BS; Buckley JP
    Eur J Pharmacol; 1977 Jul; 44(1):9-16. PubMed ID: 885163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary and systemic hemodynamic effects of delta9-tetrahydrocannabinol in conscious and morphine--chloralose-anesthetized dogs: anesthetic influence on drug action.
    Jandhyala BS; Hamed AT
    Eur J Pharmacol; 1978 Dec; 53(1):63-8. PubMed ID: 738360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic administration of delta9-tetrahydrocannabinol on the heart rate of mongrel dogs.
    Jandhyala BS; Malloy KP; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):201-4. PubMed ID: 935652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute administration of delta9-tetrahydrocannabinol on pulmonary hemodynamics of anesthetized dogs.
    Jandhyala BS; Malloy KP; Buckley JP
    Eur J Pharmacol; 1976 Jul; 38(1):183-7. PubMed ID: 954827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the hypotensive activity of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.
    Cavero I; Solomon T; Buckley JP; Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):527-40. PubMed ID: 4750101
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of delta9-tetrahydrocannabinol in conscious and anaesthetized dogs.
    Friedman E; Gershon S; Hine B; Torrelio M
    Br J Pharmacol; 1977 Apr; 59(4):561-3. PubMed ID: 858008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of central alpha-adrenoceptors in the hypotensive and bradycardic effects of (--)-delta 9-trans-tetrahydrocannabinol.
    Lokhandwala MF; Pariani HK; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1977 Mar; 42(2):107-12. PubMed ID: 191263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Participation of the cardiac sympathetic innervation in the occurrence of vagotomic and atropine tachycardia in anesthetized dogs].
    Nikol'skaia MG; Samonina GE; Udel'nov MG
    Fiziol Zh SSSR Im I M Sechenova; 1975 Oct; 61(10):1449-53. PubMed ID: 1204856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic and cardiovascular effects of chronic delta9-tetrahydrocannabinol administration in mongrel dogs.
    Jandhyala BS; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):593-607. PubMed ID: 193167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
    Estrada U; Brase DA; Martin BR; Dewey WL
    Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of pentobarbital anesthesia with digoxin-mediated bradycardia.
    Greenberg S; Englebrecht JA; Wilson WR; Ambre J
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):173-80. PubMed ID: 4757845
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog.
    Robson RD; Kaplan HR; Laforce S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):120-31. PubMed ID: 4389918
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the bradycardia induced by (-)- -trans-tetrahydrocannabinol in anesthetized dogs.
    Cavero I; Solomon T; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1973 Jun; 22(3):263-9. PubMed ID: 4354577
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.
    Cavero I; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1973 Nov; 24(2):243-51. PubMed ID: 4765747
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
    Adams MD; Earnhardt JT; Dewey WL; Harris LS
    J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cardiac chronotropic responses to some autonomic blocking agents in conscious trained dogs.
    Cavero I; Riggenbach H; Wall M; Gerold M
    Eur J Pharmacol; 1976 Oct; 39(2):193-202. PubMed ID: 976316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats.
    Kawasaki H; Watanabe S; Oishi R; Ueki S
    Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
    Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.